Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

Law Offices of Howard G. Smith reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Hims & Hers Health, Inc ...

Find insight on Innovent Biologics, Fisher & Paykel Healthcare and more in the latest Market Talks covering Health Care.

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

As a result, Hims & Hers customers will no longer have access to authentic Wegovy through the NovoCare Pharmacy. According to Novo Nordisk, the partnership was only in effect for about a month. In a ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by 11.76 ...

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...

Stocks rallied Tuesday after U.S. President Donald Trump announced a ceasefire in the Israel-Iran conflict, although the ...

Stocks rallied and oil prices fell on Tuesday after U.S. President Donald Trump announced what appears to be a shaky ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.